Max Nisen is a Bloomberg Gadfly columnist covering biotech, pharma and health care. He previously wrote about management and corporate strategy for Quartz and Business Insider.

Good morning! This is Fly Charts, the daily charts-only newsletter from Gadfly; sign up here. From a happy hour for Jack Daniel's to Chinese meat trends, here are four charts that tell you what you need to know in business today. 

Take the Money and Run?
Brown-Forman doesn't want a big, boozy buyout. But a sky high valuation and analyst skepticism about its future should lead it to reconsider.
Source: Bloomberg


Don't Call it a Comeback
A rebound (kind of) in S&P 500 earnings can't support stocks -- they still need some Trump magic.
Source: Bloomberg
Shrinking Behemoths
Trump's new FDA chief is all about biosimilars, which threatens sales of some of the biggest drugs in the world.
Source: Bloomberg
Organ of the State
China's food tastes are rapidly converging on those of the rest of the world, but it still has a ways to go.
Source: International Trade Centre
Note: "Offal" includes ungulate offal but not that of other species such as poultry or rabbits.

And don't miss Brooke Sutherland on General Electric's testy CEO: "Asked whether cranky investors should just accept that General Electric Co.'s businesses are what they are, Immelt joked that he was in Fox News mode: 'We report, you decide.' Unfortunately for him, what some investors decided to do during his presentation was jump ship."



This column does not necessarily reflect the opinion of Bloomberg LP and its owners.

To contact the author of this story:
Max Nisen in New York at

To contact the editor responsible for this story:
Mark Gongloff at